NO169638C - Formuleringsblanding med stabiliserende virkning paa alfa-interferon - Google Patents

Formuleringsblanding med stabiliserende virkning paa alfa-interferon

Info

Publication number: NO169638C
Authority: NO; Norway
Prior art keywords: active ingredient; stabilizing effect; formulation mixture; alfa interferon; ifn alpha
Prior art date: 1986-02-05

Application number

NO870441A

Other languages

English (en)

Norwegian (no)

Other versions

NO169638B (no

NO870441D0 (no

NO870441L (no

Inventor

Helmut Franz

Original Assignee

Thomae Gmbh Dr K

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-02-05

Filing date

1987-02-04

Publication date

1992-07-22

1987-02-04 Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K

1987-02-04 Publication of NO870441D0 publication Critical patent/NO870441D0/no

1987-08-06 Publication of NO870441L publication Critical patent/NO870441L/no

1992-04-13 Publication of NO169638B publication Critical patent/NO169638B/no

1992-07-22 Publication of NO169638C publication Critical patent/NO169638C/no

Links

239000000203 mixture Substances 0.000 title abstract 3
102000014150 Interferons Human genes 0.000 title 1
108010050904 Interferons Proteins 0.000 title 1
238000009472 formulation Methods 0.000 title 1
229940079322 interferon Drugs 0.000 title 1
230000000087 stabilizing effect Effects 0.000 title 1
239000004480 active ingredient Substances 0.000 abstract 3
238000012270 DNA recombination Methods 0.000 abstract 1
108010010803 Gelatin Proteins 0.000 abstract 1
229920000663 Hydroxyethyl cellulose Polymers 0.000 abstract 1
239000004354 Hydroxyethyl cellulose Substances 0.000 abstract 1
229920000159 gelatin Polymers 0.000 abstract 1
239000008273 gelatin Substances 0.000 abstract 1
235000019322 gelatine Nutrition 0.000 abstract 1
235000011852 gelatine desserts Nutrition 0.000 abstract 1
235000019447 hydroxyethyl cellulose Nutrition 0.000 abstract 1
239000003381 stabilizer Substances 0.000 abstract 1
238000011200 topical administration Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Inorganic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Zoology (AREA)
Dermatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

NO870441A 1986-02-05 1987-02-04 Formuleringsblanding med stabiliserende virkning paa alfa-interferon NO169638C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19863603444 DE3603444A1 (de)	1986-02-05	1986-02-05	Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha

Publications (4)

Publication Number	Publication Date
NO870441D0 NO870441D0 (no)	1987-02-04
NO870441L NO870441L (no)	1987-08-06
NO169638B NO169638B (no)	1992-04-13
NO169638C true NO169638C (no)	1992-07-22

Family

ID=6293372

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO870441A NO169638C (no)	1986-02-05	1987-02-04	Formuleringsblanding med stabiliserende virkning paa alfa-interferon

Country Status (20)

Country	Link
EP (1)	EP0231816B1 (da)
JP (1)	JPS62209024A (da)
KR (1)	KR870007698A (da)
AT (1)	ATE63823T1 (da)
AU (1)	AU601712B2 (da)
CA (1)	CA1295242C (da)
DD (1)	DD284602A5 (da)
DE (2)	DE3603444A1 (da)
DK (1)	DK164202C (da)
ES (1)	ES2028796T3 (da)
FI (1)	FI86144C (da)
GR (1)	GR3002270T3 (da)
HU (1)	HU196560B (da)
IE (1)	IE59697B1 (da)
IL (1)	IL81472A0 (da)
NO (1)	NO169638C (da)
NZ (1)	NZ219169A (da)
PH (1)	PH24377A (da)
PT (1)	PT84243B (da)
ZA (1)	ZA87793B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5275804A (en) *	1986-02-25	1994-01-04	E. B. Michaels Research Associates, Inc.	Process and composition for oral hygiene
US5266310A (en) *	1987-09-17	1993-11-30	Boehringer Ingelheim International Gmbh	Stabilization of therapeutically active proteins in pharmaceutical preparations
DE3731255A1 (de) *	1987-09-17	1989-04-06	Boehringer Ingelheim Int	Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
DE3803312A1 (de) *	1988-02-04	1989-08-10	Gerd Prof Dr Med Gross	Verwendung eines interferonenthaltenden gels
NZ228285A (en) *	1988-03-11	1991-08-27	Teikoku Seiyaku Kk	Pharmaceutical composition comprising a polypeptide and adapted for intravaginal administration
EP0374257B1 (en) *	1988-05-06	1994-08-31	Toray Industries, Inc.	STABLE INTERFERON $g(b) COMPOSITION
US5389676A (en) *	1991-03-22	1995-02-14	E. B. Michaels Research Associates, Inc.	Viscous surfactant emulsion compositions
US5244652A (en) *	1991-03-22	1993-09-14	E. B. Michaels Research Associates, Inc.	Viscous surface active composition
JPH07501320A (ja) *	1991-10-11	1995-02-09	ギリーズ，マーク・セドリック	インタ−フェロン・アルファによる眼線維症の治療
US5863530A (en) *	1991-10-11	1999-01-26	Spruson & Ferguson	Treating ophthalmic fibrosis using interferon-α
US6630168B1 (en)	1997-02-20	2003-10-07	Biomedicines, Inc.	Gel delivery vehicles for anticellular proliferative agents
FI106465B (fi) *	1998-06-10	2001-02-15	Suomen Punainen Risti Veripalv	Menetelmä virusturvallisten farmaseuttisten koostumusten valmistamiseksi
US6923966B2 (en)	1999-04-08	2005-08-02	Schering Corporation	Melanoma therapy
JP4536194B2 (ja) *	2000-02-17	2010-09-01	大日本住友製薬株式会社	安定な注射用製剤
RU2274442C2 (ru) *	2000-03-07	2006-04-20	Раш-Презбитериан-Ст. Лук'С Медикал Сентер	Композиции и способы улавливания и инактивации патогенных микроорганизмов и сперматозоидов
US6328987B1 (en) *	2000-11-03	2001-12-11	Jan Marini Skin Research, Inc.	Cosmetic skin care compositions containing alpha interferon
CA2464889A1 (en) *	2001-11-02	2003-05-08	Sekisui Chemical Co., Ltd.	Cytokine-inducing material and cytokine-inducing instrument
US8137677B2 (en) *	2005-10-06	2012-03-20	Allergan, Inc.	Non-protein stabilized clostridial toxin pharmaceutical compositions
EP2435139B1 (en) *	2009-05-29	2016-10-05	Innonix Technologies, Incorporated	Composition for use in decreasing the transmission of human pathogens
RU2431489C1 (ru) *	2010-05-25	2011-10-20	Федеральное государственное учреждение "Российский научный центр рентгенорадиологии Федерального агентства по высокотехнологичной медицинской помощи" (ФГУ "РНЦРР Росмедтехнологий")	Способ лечения хронических воспалительных заболеваний толстого кишечника
CN104271142B (zh) *	2012-03-01	2017-07-04	福斯特斯特林研究公司	含有α连接蛋白C‑末端(ACT)肽的局部凝胶
JP6081156B2 (ja) *	2012-11-15	2017-02-15	アルケア株式会社	ハイドロゲル
DE102012222365A1 (de)	2012-12-05	2014-06-05	Aesculap Ag	Zusammensetzung zur Anwendung bei der Prophylaxe von post-chirurgischen Adhäsionen
EP3007720A4 (en) *	2013-06-09	2016-12-07	Efranat Ltd	COMPOSITION COMPRISING THE GC MACROPHAGE ACTIVATION FACTOR AND USES THEREOF
KR102679493B1 (ko)	2017-01-31	2024-07-01	킴벌리-클라크 월드와이드, 인크.	벤조산 에스테르를 포함하는 항균 조성물 및 이를 이용한 세균 생장 억제 방법
EP4232157A4 (en)	2020-10-22	2024-08-28	Xequel Bio, Inc.	PEPTIDE FORMULATIONS AND ASSOCIATED OPHTHALMIC USES

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU1234383A (en) *	1982-03-17	1983-09-22	Inter-Yeda Ltd.	Interferon stabilised with polyvinyl-pyrrolidone
JPS6061535A (ja) *	1983-08-24	1985-04-09	エフ・ホフマン・ラ・ロシユ・ウント・コンパニ−・アクチエンゲゼルシヤフト	製薬学的組成物
JPS6069037A (ja) *	1983-09-26	1985-04-19	Sunstar Inc	エリテマト−デス治療用外用剤
DE3484951D1 (de) *	1983-10-14	1991-09-26	Sumitomo Pharma	Verlaengerte praeparate mit verzoegerter abgabe.
US4680175A (en) *	1984-02-07	1987-07-14	Interferon Sciences, Inc.	Interferon administration vehicles
CA1248450A (en) *	1984-04-05	1989-01-10	Kazuo Kigasawa	Soft patch
JPS60228422A (ja) *	1984-04-26	1985-11-13	Suntory Ltd	安定化された生理活性物質製剤
JPS60260523A (ja) *	1984-06-07	1985-12-23	Asahi Chem Ind Co Ltd	インタ−フエロンの凍結乾燥医薬組成物

1986
- 1986-02-05 DE DE19863603444 patent/DE3603444A1/de not_active Withdrawn
1987
- 1987-01-21 DE DE8787100792T patent/DE3770280D1/de not_active Expired - Lifetime
- 1987-01-21 EP EP87100792A patent/EP0231816B1/de not_active Expired - Lifetime
- 1987-01-21 ES ES198787100792T patent/ES2028796T3/es not_active Expired - Lifetime
- 1987-01-21 AT AT87100792T patent/ATE63823T1/de not_active IP Right Cessation
- 1987-02-03 DD DD87299676A patent/DD284602A5/de not_active IP Right Cessation
- 1987-02-03 FI FI870457A patent/FI86144C/fi not_active IP Right Cessation
- 1987-02-03 CA CA000528832A patent/CA1295242C/en not_active Expired - Lifetime
- 1987-02-04 NZ NZ219169A patent/NZ219169A/en unknown
- 1987-02-04 NO NO870441A patent/NO169638C/no unknown
- 1987-02-04 JP JP62024423A patent/JPS62209024A/ja active Pending
- 1987-02-04 PT PT84243A patent/PT84243B/pt not_active IP Right Cessation
- 1987-02-04 IL IL81472A patent/IL81472A0/xx not_active IP Right Cessation
- 1987-02-04 DK DK058387A patent/DK164202C/da not_active IP Right Cessation
- 1987-02-04 HU HU87385A patent/HU196560B/hu not_active IP Right Cessation
- 1987-02-04 ZA ZA87793A patent/ZA87793B/xx unknown
- 1987-02-04 IE IE29587A patent/IE59697B1/en not_active IP Right Cessation
- 1987-02-04 AU AU68292/87A patent/AU601712B2/en not_active Ceased
- 1987-02-05 PH PH34815A patent/PH24377A/en unknown
- 1987-02-05 KR KR870000912A patent/KR870007698A/ko not_active Ceased
1991
- 1991-07-08 GR GR91400966T patent/GR3002270T3/el unknown

Also Published As

Publication number	Publication date
NO169638B (no)	1992-04-13
IL81472A0 (en)	1987-09-16
ES2028796T3 (es)	1992-07-16
ZA87793B (en)	1988-10-26
HUT43494A (en)	1987-11-30
EP0231816A2 (de)	1987-08-12
EP0231816B1 (de)	1991-05-29
IE870295L (en)	1987-08-05
FI86144B (fi)	1992-04-15
PT84243B (pt)	1989-09-14
FI870457A0 (fi)	1987-02-03
HU196560B (en)	1988-12-28
DK58387A (da)	1987-08-06
NZ219169A (en)	1990-04-26
PT84243A (de)	1987-03-01
KR870007698A (ko)	1987-09-21
NO870441D0 (no)	1987-02-04
NO870441L (no)	1987-08-06
JPS62209024A (ja)	1987-09-14
CA1295242C (en)	1992-02-04
FI86144C (fi)	1992-07-27
DD284602A5 (de)	1990-11-21
DK164202B (da)	1992-05-25
DK58387D0 (da)	1987-02-04
AU601712B2 (en)	1990-09-20
DE3603444A1 (de)	1987-08-06
AU6829287A (en)	1987-08-06
ATE63823T1 (de)	1991-06-15
PH24377A (en)	1990-06-13
IE59697B1 (en)	1994-03-23
GR3002270T3 (en)	1992-12-30
FI870457L (fi)	1987-08-06
EP0231816A3 (en)	1987-09-23
DE3770280D1 (de)	1991-07-04
DK164202C (da)	1992-10-19

Publication	Publication Date	Title
NO870441L (no)	1987-08-06	Farmasoeytiske preparatformer for stabilisering av alfa-interferon.
DK203787D0 (da)	1987-04-22	Praeparat til nasal administrering
DE3581819D1 (de)	1991-04-04	Pyridazinamine wirksam gegen viren.
IL85523A (en)	1992-11-15	Stable alpha interferon complex,its preparation and pharmaceutical compositions comprising it
SE8505112D0 (sv)	1985-10-29	Novel pharmacological compounds
ATE180969T1 (de)	1999-06-15	Pharmazeutische zusammensetzungen enthaltend urodeoxycholicsäure
DK305087A (da)	1987-12-17	Buprenorphinholdigt farmaceutisk suppositorium
DK516288A (da)	1989-03-18	Stabilisering af terapeutisk aktive proteiner i farmaceutiske praeparater
DK396286A (da)	1987-02-24	Injicerbar formulering med forsinket frigivelse af den aktive bestanddel
DE3777769D1 (de)	1992-04-30	Pharmazeutische produkte.
NO863027L (no)	1987-01-30	Peptidpreparater med kontinuerlig avgivelse.
ATE27813T1 (de)	1987-07-15	N-substituierte 1-(4'-alkylsulfonylphenyl)-2amino-1,3-propanediol-derivate.
DE68906572D1 (de)	1993-06-24	Peptide mit inhibitorischer wirkung auf enzymatische systeme, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
GB1351437A (en)	1974-05-01	N-substituted amino acids having antiviral anti-inflammatory or anti-tumour activity
ATE30417T1 (de)	1987-11-15	N-substituierte 1-(4'-alkylthiophenyl)-2-amino1,3-propanediol-derivate.
ES2016052A6 (es)	1990-10-01	Procedimiento para preparar derivados de adenosinmonofosfonato (amp) ciclico y de guanosinmonofosfonato (gmp) ciclico.
DK0578535T3 (da)	1996-12-09	Hidtil ukendt peptid-derivater, der er aktive i celleadhæsionsprocesser, fremgangsmåde til deres fremstilling samt farmaceutiske sammensætninger indeholdende derivarerne
KR910009280A (ko)	1991-06-28	원발성 흉막암 치료용 제약 조성물의 제조에 있어서 감마 인터페론 활성을 갖는 폴리펩티드의 용도
IT1216103B (it)	1990-02-22	Peptidi ad attivita' farmaceutica.
IT8723007A0 (it)	1987-12-15	Composizioni farmaceutiche per uso orale ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo, e procedimento per prepararle